The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Levin Jeremy M since 2010.
This trader's CIK number is 1256153.
At the time of last reporting, Levin Jeremy M was the CEO of Ovid Therapeutics Inc.. (stock ticker symbol OVID).
Also see all insider trading activities at Ovid Therapeutics Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2011 | BMY | 0 | $0 | 0 | $0 | 28,667 | $0 |
2010 | BMY | 0 | $0 | 0 | $0 | 10,000 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | OVID | 18,248 | $50,364 | 0 | $0 | 0 | $0 |
2020 | OVID | 8,488 | $49,569 | 0 | $0 | 0 | $0 |
2019 | OVID | 285,000 | $600,000 | 0 | $0 | 0 | $0 |
2017 | OVID | 15,334 | $109,638 | 0 | $0 | 0 | $0 |
1. Bristol Myers Squibb Co (BMY)
2. Ovid Therapeutics Inc. (OVID)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2011-10-01 | BMY | Option Ex | 10,000 | .00 | 0 |
2011-03-04 | BMY | Option Ex | 1,397 | .00 | 0 |
2011-03-02 | BMY | Option Ex | 2,307 | .00 | 0 |
2011-03-03 | BMY | Option Ex | 2,019 | .00 | 0 |
2011-03-01 | BMY | Option Ex | 12,944 | .00 | 0 |
2010-10-01 | BMY | Option Ex | 10,000 | .00 | 0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-03-18 | OVID | Buy | 18,248 | 2.76 | 50,364 |
2020-08-28 | OVID | Buy | 8,488 | 5.84 | 49,569 |
2019-10-08 | OVID | Buy | 60,000 | 2.50 | 150,000 |
2019-02-22 | OVID | Buy | 75,000 | 2.00 | 150,000 |
2019-02-22 | OVID | Buy | 75,000 | 2.00 | 150,000 |
2019-02-22 | OVID | Buy | 75,000 | 2.00 | 150,000 |
2017-08-25 | OVID | Buy | 15,334 | 7.15 | 109,638 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Levin Jeremy M (CEO of Ovid Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.